Maturation of NK1 receptor involvement in the nociceptive response to formalin

Synapse

Volumn 36, Issue 4, 2000, Pages 254-266

  King, Tamara E ^a,b   Cheng, Jianxin ^b   Wang, Shaoning ^b   Barr, Gordon A ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

NK1 receptor; Nociceptive response; Pain

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; FORMALDEHYDE; NEUROKININ;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENE EXPRESSION; NOCICEPTION; NONHUMAN; ONCOGENE C FOS; PAIN RECEPTOR; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; FORMALDEHYDE; HINDLIMB; INJECTIONS; INJECTIONS, SPINAL; INJECTIONS, SUBCUTANEOUS; NOCICEPTORS; PIPERIDINES; RATS; RATS, LONG-EVANS; RECEPTORS, NEUROKININ-1; STEREOISOMERISM;

EID: 0034659601     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(20000615)36:4<254::AID-SYN2>3.0.CO;2-A     Document Type: Article

References (47)

1. Barr GA. 1998. Maturation of the biphasic behavioral and heart rate response in the formalin test. Pharmacol Biochem Behav 60:329-35.
2. Barr GA. 1992. Neuropharmaco-ontogeny: concepts and methods of study. In: Shair HN, Barr GA, Hofer MA, editors. Developmental psychology: new methods and changing concepts. New York: Oxford University Press, p 321-341.
3. Barr GA, Miya DY, Paredes W. 1992. Analgesic effects of intraventricular and intrathecal injection of morphine and ketocyclazocine in the infant rat. Brain Res 584:83-91.
4. Birch PJ, Harrison SM, Hayes AG, Rogers H, Tyers MB. 1992. The non-peptide NK1 receptor antagonist, (+/-)-CP-96,345, produces antinociceptive and anti-oedema effects in the rat. Br J Pharmacol 105:508-10.
5. Buritova J, Honore P, Besson JM. 1996. Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat. Pain 67:379-89.
6. Chapman V, Dickenson AH. 1993. The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord. Neuroscience Letters 157:149-52.
7. Charlton CG, Heike CJ. 1986. Ontogeny of substance P receptors in rat spinal cord: quantitative changes in receptor number and differential expression in specific loci. Brain Res 394:81-91.
8. Coimbra A, Ribeiro, Da Silva A, Pignatelli D. 1986. Rexed's laminae and the acid phosphatase (FRAP)-band in the superficial dorsal horn of the neonatal rat spinal cord. Neurosci Lett 71:131-6.
9. Cridland RA, Henry JL. 1986. Comparison of the effects of substance P, neurokinin A, physalaemin and eledoisin in facilitating a nociceptive reflex in the rat. Brain Res 381:93-9.
10. De Biasi S, Rustioni A. 1988. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci USA 85:7820-4.
11. Fitzgerald M. 1991. Development of pain mechanisms. Br Med Bull 47:667-75.
12. Fitzgerald M, Gibson S. 1984. The postnatal physiological and neurochemical development of peripheral sensory C fibres. Neuroscience 13:933-44.
13. Fitzgerald M, Zeller WP, Goto M, Anderson CL, Hurley RM. 1988. Concurrent clinical and metabolic derangements in the newborn rat: a late phase sepsis model. Ann Clin Lab Sci 18:229-34.
14. Garland AM, Grady EF, Lovett M, Vigna SR, Frucht MM, Krause JE, Bunnett NW. 1996. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors. Mol Pharmacol 49:438-46.
15. Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel JF, Blanchard JC, Laduron PM. 1991. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci USA 88:10208-12.
16. Guy ER, Abbott FV. 1992. The behavioral response to formalin in preweanling rats. Pain 51:81-90.
17. Holson RR, Pearce B. 1992. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol 14:221-8.
18. Honore P, Buritova J, Besson JM. 1996. Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat. Br J Pharmacol 118:671-80.
19. Karlsson U, Nasstrom J, Berge OG. 1994. (+/-)-CP-96,345, an NK1 receptor antagonist, has local anaesthetic-like effects in a mammalian sciatic nerve preparation. Regul Pept 52:39-46.
20. Liu H, Mantyh PW, Basbaum AI. 1997. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 386: 721-4.
21. Lombet A, Spedding M. 1994. Differential effects of non-peptidic tachykinin receptor antagonists on Ca2+ channels. Eur J Pharmacol 267:113-5.
22. Mantyh PW, Allen CJ, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE. 1995. Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo. Proc Natl Acad Sci USA 92: 2622-6.
23. Marvizon JC, Martinez V, Grady EF, Bunnett NW, Mayer EA. 1997. Neurokinin 1 receptor internalization in spinal cord slices induced by dorsal root stimulation is mediated by NMDA receptors. J Neurosci 17:8129-36.
24. McLean S, Snider RM, Desai MC, Rosen T, Bryce DK, Longo KP, Schmidt AW, Heym J. 1993. CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor. Regul Pept 46:329-31.
25. Mjellem-Joly N, Lund A, Berge OG, Hole K. 1991. Potentiation of a behavioural response in mice by spinal coadministration of substance P and excitatory amino acid agonists. Neurosci Lett 133: 121-4.
26. Moochhala SM, Sawynok J. 1984. Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization. Br J Pharmacol 82:381-8.
27. Nagahisa A, Asai R, Kanai Y, Murase A, Tsuchiya NM, Nakagaki T, Shieh TC, Taniguchi K. 1992. Non-specific activity of (+/-)-CP-96,345 in models of pain and inflammation. Br J Pharmacol 107: 273-5.
28. Paredes W, Hughes HE, Giordano J, Barr GA. 1990. Methods of injecting drugs directly into the spinal cord of neonatal rats. Lab Animal 19:39-41.
29. Pickel VM, Sumal KK, Miller RJ. 1982. Early prenatal development of substance P and enkephalin-containing neurons in the rat. J Comp Neurol 210:411-22.
30. Piercey MF, Schroeder LA, Folkers K, Xu JC, Horig J. 1981. Sensory and motor functions of spinal cord substance P. Science 214:1361-3.
31. Radhakrishnan V, Henry JL. 1995. Antagonism of nociceptive responses of cat spinal dorsal horn neurons in vivo by the NK-1 receptor antagonists CP-96,345 and CP-99,994, but not by CP-96,344. Neuroscience 64:943-58.
32. Ruda MA, Bennett GJ, Dubner R. 1986. Neurochemistry and neural circuitry in the dorsal horn. Prog Brain Res 66:219-68.
33. Rupniak NM, Webb JK, Williams AR, Carlson E, Boyce S, Hill RG. 1995. Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils. Br J Pharmacol 116:1937-43.
34. Rupniak NMJ, Boyce S, Williams AR, Cook G, Longmore J, Seabrook GR, Caeser M, Iversen SD, Hill RG. 1993. Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580. British Journal of Pharmacology 110:1607-13.
35. Sakurada T, Katsumata K, Yogo H, Tan NK, Sakurada S, Ohba M, Kisara K. 1995. The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test. Pain 60:175-80.
36. Santos AR, Calixto JB. 1997. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice. Neuropeptides 31:381-9.
37. Seguin L, Le Marouille , Girardon S, Millan MJ. 1995. Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent. Pain 61:325-43.
38. Smith G, Harrison S, Bowers J, Wiseman J, Birch P. 1994. Non-specific effects of the tachykinin NK1 receptor antagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil. Eur J Pharmacol 271:481-7.
39. Teng CJ, Abbott FV. 1998. The formalin test: a dose-response analysis at three developmental stages. Pain 76:337-47.
40. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. 1992. The formalin test: an evaluation of the method [see comments]. Pain 51:5-17.
41. Traub RJ. 1996. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain 67:151-61.
42. Velazquez RA, Kitto KF, Larson AA. 1997. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse. J Pharmacol Exp Ther 281:1231-7.
43. Williams S, Evan G, Hunt SP. 1990. Spinal c-fos induction by sensory stimulation in neonatal rats. Neurosci Lett 109:309-14.
44. Yamamoto T, Yaksh TL. 1991. Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci 49:1955-63.
45. Yashpal K, Pitcher GM, Henry JL. 1995. Noxious peripheral stimulation produces antinociception mediated via substance P and opioid mechanisms in the rat tail-flick test. Brain Res 674:97-103.
46. Yi DK, Barr GA. 1995. The induction of Fos-like immunoreactivity by noxious thermal, mechanical and chemical stimuli in the lumbar spinal cord of infant rats. Pain 60:257-65.
47. Yi DK, Barr GA. 1997. Formalin-induced c-fos expression in the spinal cord of fetal rats. Pain 73:347-54.